mirtazapine has been researched along with Apraxia in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takekoshi, A | 1 |
| Yoshikura, N | 1 |
| Ozawa, K | 1 |
| Ikoma, Y | 1 |
| Kitagawa, J | 1 |
| Takeshima, A | 1 |
| Otsuki, M | 1 |
| Nakamichi, K | 1 |
| Saijo, M | 1 |
| Ohe, N | 1 |
| Mochizuki, K | 1 |
| Kakita, A | 1 |
| Shimohata, T | 1 |
1 other study available for mirtazapine and Apraxia
| Article | Year |
|---|---|
[A Patient with Progressive Multifocal Leukoencephalopathy Who Developed Bálint Syndrome Improved by Combination Therapy Using Mefloquine and Mirtazapine].
Topics: Apraxias; Brain; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic | 2019 |